Skip to main content
UTHR logo

UTHR · UNITED THERAPEUTICS Corp

Track UTHR — free
Market Cap
$22.11B
Shares
42.89M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-08-05 Earnings conference call (announced in 8-K) Earnings call
2026-08-05 United Therapeutics Second Quarter 2026 Financial Results Earnings call
2026-06-03 Jefferies Global Healthcare Conference Conference
2026-05-19 RBC Capital Markets Global Healthcare Conference Conference
2026-05-06 Earnings conference call (announced in 8-K) Earnings call
2026-05-06 United Therapeutics First Quarter 2026 Financial Results Earnings call
2026-03-09 Leerink Global Healthcare Conference Conference
2026-03-02 TD Cowen Health Care Conference Conference
2026-03-02 Phase 3 ADVANCE OUTCOMES Clinical Trial Results Earnings call
2026-02-25 Earnings conference call (announced in 8-K) Earnings call
2026-02-25 United Therapeutics Fourth Quarter and Full Year 2025 Financial Results Earnings call
2026-01-12 44th Annual J.P. Morgan Healthcare Conference Conference
2025-11-18 Jefferies Global Healthcare Conference Conference
2025-11-10 UBS Global Healthcare Conference Conference
2025-10-29 United Therapeutics Third Quarter 2025 Financial Results Earnings call
2025-09-28 Phase 3 TETON-2 Results Conference Call Earnings call
2025-09-23 Bernstein 2nd Annual Healthcare Forum Webcast
2025-09-08 Morgan Stanley 23rd Annual Global Healthcare Conference Conference
2025-07-30 United Therapeutics Second Quarter 2025 Financial Results Earnings call
2025-04-30 United Therapeutics First Quarter 2025 Financial Results Earnings call
2025-03-11 Leerink Partners Global Healthcare Conference Conference
2025-03-03 TD Cowen Health Care Conference Conference
2025-02-26 United Therapeutics Fourth Quarter and Full Year 2024 Financial Results Earnings call
2025-01-13 J.P. Morgan Healthcare Conference Conference
2024-10-30 United Therapeutics Third Quarter 2024 Financial Results Earnings call

Source: https://ir.unither.com/

Key facts CIK 1082554 CUSIP 91307C102 13F (30d) 632 filings 602 filers Visit website Investor relations